{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:07:52Z","timestamp":1792030072737,"version":"4.4.0"},"reference-count":37,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunology Research"],"published-print":{"date-parts":[[2022,9,19]]},"abstract":"<jats:p>Objective. To investigate the risk factors of axillary lymph node metastasis in patients with invasive breast cancer. Methods. This study retrospectively included 122 cases of invasive breast cancer patients admitted to the First Medical Center of PLA General Hospital from January 2019 to September 2020. According to postoperative pathological results, axillary lymph node metastasis was divided into axillary lymph node metastasis (ALNM) group (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>n<\/a:mi>\n                     <\/a:math>\n                  <\/jats:inline-formula>\u2009=40) and non-axillary lymph node metastasis (NALNM) group (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>n<\/c:mi>\n                     <\/c:math>\n                  <\/jats:inline-formula>\u2009=82). General demographic information was collected and compared between the two groups. Collected pathological results included lymphovascular invasion (LVI) and the expression of estrogen receptor (ER), progestogen receptor (PR), human epidermal growth factor receptor 2 (HER-2), and Ki-67 detected by immunohistochemistry. Imaging parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) including apparent diffusion coefficient (ADC), early enhanced rate, and time-intensity curve (TIC) were also included into univariate analysis. The variables with differences between the two groups were compared by univariate analysis, and the related factors of axillary lymph node metastasis were analyzed by logistic regression model. Results. There was no significant difference in general demographic information between the two groups. No significant differences were found in the positive rates of HER-2, ER, PR, Ki-67, pathological types, and clavicular lymph node metastasis and skin chest wall invasion between the two groups (<jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&gt;<\/e:mo>\n                        <e:mn>0.05<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>). The proportion of LVI in ALNM group was significantly higher than that in NALNM group (37.50% vs. 6.10%, <jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.001<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula>). The proportion of breast cancer on the left side in the ALNM group was higher than that in the NALNM group, and the difference was statistically significant (70.00% vs. 47.56%, <jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>=<\/i:mo>\n                        <i:mn>0.019<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>). There were no significant differences in the imaging parameters obtained by DCE-MRI between the two groups. Binary logistics regression analysis showed that LVI (OR\u2009=12.258, 95% CI\u2009=3.681-40.812, <jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>&lt;<\/k:mo>\n                        <k:mn>0.001<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula>) and left breast cancer (OR\u2009=3.598, 95% CI\u2009=1.404-9.219, <jats:inline-formula>\n                     <m:math xmlns:m=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\">\n                        <m:mi>P<\/m:mi>\n                        <m:mo>=<\/m:mo>\n                        <m:mn>0.008<\/m:mn>\n                     <\/m:math>\n                  <\/jats:inline-formula>) were risk factors for axillary lymph node metastasis in patients with invasive breast cancer. Conclusion. The formation of vascular tumor thrombi in breast cancer tissue and left breast cancer are risk factors for axillary lymph node metastasis in invasive breast cancer and might be helpful for preoperative detailed assessment of the patient\u2019s condition.<\/jats:p>","DOI":"10.1155\/2022\/7150304","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T03:20:14Z","timestamp":1663644014000},"page":"1-7","source":"Crossref","is-referenced-by-count":12,"title":["Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5774-1705","authenticated-orcid":true,"given":"Hongye","family":"Chen","sequence":"first","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchao","family":"Meng","sequence":"additional","affiliation":[{"name":"General Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, 066600 Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Military Wounded Patient Management, The Eighth Medical Center of PLA General Hospital, Beijing 100091, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-3729","authenticated-orcid":true,"given":"Yuhui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.12.010"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05541-5"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.21203\/rs.2.24640\/v1"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-584"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S264349"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.3390\/nano11030572"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13238"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0427"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32454-0"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx364.010"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01319-3"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06194-8"},{"issue":"146","key":"13","first-page":"7","article-title":"Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI\/DCE-MRI and immunohistochemical tumor markers","volume":"27","author":"A. Allarakha","year":"2019","journal-title":"Discovery Medicine"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1159\/000508337"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85309-z"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-546"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2021.2358"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12655"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0256"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.7150\/jca.46183"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12910"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-0729-7"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-020-01120-0"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8404035"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2020.09.001"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03606-6"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20180023"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.541849"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1002\/mp.14538"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.8013"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2005.06.008"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5943"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24469"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000679"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32381-3"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.4067\/S0034-98872019000500557"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05630-5"}],"container-title":["Journal of Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/7150304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/7150304.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/7150304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T03:20:19Z","timestamp":1663644019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/jir\/2022\/7150304\/"}},"subtitle":[],"editor":[{"given":"Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":37,"alternative-id":["7150304","7150304"],"URL":"https:\/\/doi.org\/10.1155\/2022\/7150304","relation":{},"ISSN":["2314-7156","2314-8861"],"issn-type":[{"value":"2314-7156","type":"electronic"},{"value":"2314-8861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}